Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. I. Social interactions

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 2, 1997, Pages 287-293

  Cutler, M G ^a   Rodgers, R J ^b   Jackson, J E ^a,b  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

antidepressants; anxiety; anxiolytics; buspirone; mice; ondansetron; social interaction; tianepti ne

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; ONDANSETRON; RECEPTOR SUBTYPE; SEROTONIN AGONIST; TIANEPTINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SOCIAL BEHAVIOR;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BUSPIRONE; MALE; MICE; ONDANSETRON; SEROTONIN AGONISTS; SOCIAL BEHAVIOR; THIAZEPINES;

EID: 0031057233     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00241-9     Document Type: Article

References (55)

1. Andrew, N.; File, S. E. Handling history modifies effects of drugs in the elevated plus-maze test of anxiety. Eur. J. Pharmol. 235:109-112; 1993.
2. 3H] acetylcholine from rat entorrhinal cortex in vivo. Br. J. Pharmacol. 98:773:1989.
3. Bodnoff, S. R.; Suranyi-Cadotte, B.; Aitken, D. H.; Quirion, R.; Meaney, M. J. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 95:298-302; 1988.
4. Carli, M.; Prontera, C.; Samanin, R. Evidence that central 5-hydroxytrptaminergic neurones are involved in the anxiolytic activity of buspirone. Br. J. Pharmacol. 96:829-836; 1989.
5. Cassella, J. V.; Davis, M. Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats. Psychopharmacology 87:278-282; 1985.
6. 2-adrenoceptor mediation. Psychopharmacology 118:425-436; 1995.
7. Cole, J. C.; Rodgers, R. J. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology 114:228-296; 1994.
8. Cole, J. C.; Rodgers, R. J. An ethological analysis of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus maze. Pharmacol. Biochem. Behav., 52: 473-478, 1995.
9. Commissaris, R. L.; Humrich J.; Johns, J.; Geere, D. G.; Fontana, D. J. The effects of selective and non-selective monoamine oxidase (MAO) inhibitors on conflict behaviour in the rat. Behav. Pharmacol. 6:195-202; 1995.
10. 3 receptors in the central nervous system. Br. J. Pharmacol. 6:195-202; 1995.
11. Costall, B.; Domeney, A. M.; Gerrard, P. A.; Kelly, M. E.; Naylor, R. J. Zacopride: anxiolytic profile in rodent and primate models of anxiety. J. Pharm. Pharmacol. 40:302-305; 1988a.
12. Costall, B.; Domeney, A. M.; Jones, B. J.; Kelly, M. E.; Gerrard, P. A.; Naylor, P. J.; Tyers, M. B. Influence of GR 38032F on the behavioural consequences of ceasing subchronic treatment with drugs of abuse. Br. J. Pharmacol. 96:905, 1988b.
13. 3 receptor antagonists. Br. J. Pharmacol. 97:475; 1989.
14. 3 receptor antagonist, BRL 43494 (Granisetron) on behaviour during social interactions in male and female mice. Neuropharmacology 30:299-306; 1991.
15. 3 antagonists, granisetron and BRL 46470, on the behaviour of intruder mice. Br. J. Pharmacol. 104:2541; 1992.
16. Cutler, M. G. Anxiolytic drugs; Does ethopharmacological analysis indicate commonalities in their mode of action?/ In; Cooper, S. J.; Hendrie, C. A., eds. Ethology and psychopharmacology. Chichester: Wiley; 1994:45-58.
17. Cutler, M. G. Rodgers, J. R.; Jackson, J. E. Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. Pharmacol. Biochem. Behav. (in press).
18. Dixon, A. K.; Fisch, H. U.; McAllister, K. H. Ethopharmacology: A biological approach to the study of drug-induced effects in behavior. Adv. Stud. Behav. 19:171-204; 1990.
19. Eison, A. S.; Temple, D. L. Buspirone: Review of its pharmacology and current perspectives on its mechanism of action. Am. J. Med. 80:[Suppl. 3B]; 1-9; 1986.
20. Elliott, J. M.; Heal, D. J.; Marsden, C. A. Experimental approaches to anxiety and depression. Chichester: Wiley; 1992.
21. 3 receptors within the CNS. Naunyn. Schmiedeberg's Arch. Pharmacol. 333:191-197; 1986.
22. File, S. E. Behavioural detection of anxiolytic action. In: Elliott J. M.; Heal D. J.; Marsden C. A., eds. Experimental approaches to anxiety and depression. Chichester: Wiley; 1992:25
23. 3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology 99:248-251; 1989.
24. File, S. E.; Mabbutt, P. S. Effects of tianeptine in animal models of anxiety and on learning and memory. Drug. Dev. Res 23:47-56; 1991.
25. File, S. E.; Andrews, N. Zangrossi, H. Tianeptine counteracts the anxiogenic effects of benzodiazepine withdrawal but not those of exposure to cat odour. Eur. Psychiatry. 8:Suppl 2, 75s-80s; 1993.
26. File, S. E.; Andrews, N.; Al-Farhan, M. Anxiogenic responses of rats on withdrawal from chronic ethanol treatment: Effects of tianeptine. Alcohol Alcoholism 28:281-286; 1993b.
27. 3 receptor antagonist, BRL 46470, on the social behaviour of mice. Neuropharmacology 31:207-213; 1992a.
28. 3 receptor antagonist, BRL 46470A, on the behaviour of mice in two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage. Neuropharmacology 31:743-748; 1992b.
29. Gao, B.; Cutler, M. G. Effects of quinpirole on the behaviour shown by mice in the light-dark box and during social interactions. Neuropharmacology. 32:93-100; 1993.
30. Goa, K.; Ward, A. Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32:114-129; 1986.
31. 1A partial agonists gepirone, ipsarone and buspirone on local cerebral glucose utilization in the conscious rat. Psychopharmacology 106:97-101; 1992.
32. Griebel, S.; Moreau, J. L.; Jenck, F.; Misslin, R.; Martin, J. R. Acute and chronic treatment with 5-HT uptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 113:463-470; 1994.
33. 3 receptor agonists 1-phenylbiguanide, and M-chlorophenylbiguanide in rats. J. Pharm. Exp. Ther. 294:1440-1449; 1993.
34. Hoehn-Saric, R.; McLeod, D. R. Depression and anxiety. In: DenBoer, J. A.; Siten J. M., Handbook of depression and anxiety. New York: Marcel Dekker; 1994: 119-158.
35. Invernizzi, G.; Aguglia, E.; Bertolino, A.; Casacchia, M.; Ciani, M.; Marchesi, G. F.; Nardini, M.; Rapisarda, V. The efficiacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study vs amitriptyline. Neuropsychobiology 30:85-93; 1994.
36. 3 receptor antagonist. Br. J. Pharmacol. 93:985-993; 1988.
37. Kelly, J. P.; Leonard, B. E. The effects of tianeptine and sertraline in three animal models of depression. Neuropharmacology 33: 1011-1016; 1994.
38. Kilts, C. D.; Commissaris, R. L.; Rech, R. H. Comparison of anticonflict drug effects in three experimental animal models of anxiety. Psychopharmacology 74:290-296; 1981.
39. Lecrubier, V,; Puech, A. J.; Azcona, S; Bailey, P. E.; Lataste, X. A. A randomized double-blind placebo controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology 112:129-133; 1993.
40. Mackintosh J. H. Social behaviour of the laboratory mouse. PhD Thesis, University of Birmingham; 139-155; 1966.
41. Martin, J. R.; Moreau, J. -L.; Jenck, F.; Cumin, R. Acute and chronic administration of buspirone fails to yield anxiolytic-like effects in a mouse operant punishment paradigm. Pharmacol. Biochem. Behav. 46:905-910; 1993.
42. Mason, P.; Skinner, J.; Luttinger, D. Two tests in rats for antianxiety attenuating antidepressants. Psychopharmacology 92:30-34; 1987.
43. Mennini, T.; Mocaer, E.; Garattini, S. Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn-Schmeideberg's Arch. Pharmacol. 336:478-482; 1987.
44. Nutt, D. J. Anxiety and its therapy today and tomorrow. In: Briley M.; File S. E.; New concepts in Anxiety. London: MacMillan; 1991: 1-12.
45. Pich, E. M.; Samanin, R. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: Possible role of dopamine. Psychopharmacology 89:125-130; 1986.
46. Rickels, K.; Downing, R.; Schweizer, E.; Hassman, H. Antidepressants for the treatment of generalized anxiety disorder. Arch. Gen. Psychiat. 50:884-895; 1993.
47. 3 and denzodiazepines: The Comparative Behavioural Pharmacology. Chichester; Wiley; 1991:195-231.
48. 3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety in mice. Psychopharmacology 117:306-312; 1995.
49. Rodgers, R. J.; Cutler, M. G.; Jackson, J. E. Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. II. the elevated plus-maze. Pharmacol. Biochem. Behav. (in press).
50. Rodgers, R. J.; Cutler, M. G.; Jackson, J. E. 1996b, Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine II The elevated plus-maze. Pharmacol. Biochem. Behav.; (in press).
51. 3 Antagonists and Benzodiazepines: their Comparative Behavioural Pharmacology. Chichester: Wiley; 1991: 31-57.
52. Schefke, D. M.; Fontana, D. J.; Commissaris, R. L. Anti-conflict efficacy of buspirone following acute versus chronic treatment. Psychopharmacology 99:427-429; 1989.
53. Taylor, D. P.; Moon, S. L. Buspirone and related compounds as alternative anxiolytics. Neuropeptides 19 [Suppl 1]:15-19; 1991.
54. Whitton, P. S.; Sarna, G. S.; Datla, K. P.; Curzon, G. Effects of tianeptine on stress-induced behavioural deficits and 5-HT dependent behaviour. Psychopharmacology 104:81-85; 1991.
55. Wilde, M. I.; Benfield, P. Tianeptine. A review of its pharmacodynamic and pharacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 49:411-439; 1995.